1 – 9 of 9
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Comparative financing analysis and political economy of noncommunicable diseases
(
- Contribution to journal › Article
- 2017
-
Mark
Pharmaceutical expenditure dynamics in the Balkan countries
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Within the triangle of healthcare legacies : comparing the performance of South-Eastern European health systems
(
- Contribution to journal › Article
- 2016
-
Mark
Comparison of historical medical spending patterns among the BRICS and G7
(
- Contribution to journal › Debate/Note/Editorial
- 2015
-
Mark
Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson's disease in the UK and Germany
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness analysis of ferric carboxymaltose in iron-deficient patients with chronic heart failure in Sweden.
(
- Contribution to journal › Article
-
Mark
Radiation therapy remains the key cost driver of oncology inpatient treatment
(
- Contribution to journal › Article
- 2014
-
Mark
Cost-effectiveness of add-on treatments to metformin in a Swedish setting: liraglutide vs sulphonylurea or sitagplitin.
(
- Contribution to journal › Article
- 2013
-
Mark
Cost-effectiveness of insulin detemir compared with NPH insulin in people with type 2 diabetes in Denmark, Finland, Norway, and Sweden.
2013) In Journal of Medical Economics(
- Contribution to journal › Article